<unk>  is a herbal supplement proposed to support functional recovery after strokes. There were two formulations of<unk> : MLC601<unk> TM) was first developed. Since 2018 MLC601 formulation is no longer on the market, and has been replaced by MLC901<unk> TMII), a simplified formulation containing only 9 botanical ingredients. It can be administered orally or through a feeding tube. Research has found the drug to be of no benefit for aiding stroke recovery. Common side effects include abdominal discomfort, headaches, dry mouth, nausea, vomiting, and diarrhea. Though very rare, some patients have reported serious adverse events in clinical trials (jaundice, hypokalemia, seizures, and recurring strokes).<unk>  was first registered and marketed in China in 2001. It was patented in the United States in 2013, but has not been approved by the FDA.<unk>  is distributed by Moleac, and is derived from traditional Chinese medicine. According to the CEO of Moleac,<unk>  is sold in at least 25 countries, and 20,000 people have taken it.
NeuroAiD
OHVIRA
ICPC-2 PLUS
ScotSTAR
DCAP-BTLS
Pro-ana
HeRAMS
PATH 